Form EFFECT Neuphoria Therapeutics
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 8, 2025 12:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thermal Master Officially Launches All-new DV2 and T2MAX Across Europe and North America
- Hyundai Motor America Reports Record-Breaking July 2026 Sales
- Residential Plumbing Expert Tim Martin Shares Simple Signs Your Water Heater May Be Failing in HelloNation
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
